|
Volumn 38, Issue 8, 1999, Pages 628-632
|
Betamethasone valerate foam 0.12%: A novel vehicle with enhanced delivery and efficacy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BETAMETHASONE VALERATE;
ADULT;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG BIOAVAILABILITY;
DRUG DELIVERY SYSTEM;
DRUG EFFICACY;
DRUG PENETRATION;
DRUG SAFETY;
FEMALE;
HUMAN;
HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
PSORIASIS;
RANDOMIZED CONTROLLED TRIAL;
TOPICAL DRUG ADMINISTRATION;
TREATMENT OUTCOME;
ADMINISTRATION, CUTANEOUS;
ADOLESCENT;
ADULT;
ANTI-INFLAMMATORY AGENTS;
BETAMETHASONE 17-VALERATE;
BIOLOGICAL AVAILABILITY;
CADAVER;
DOSAGE FORMS;
DOUBLE-BLIND METHOD;
FEMALE;
FOLLOW-UP STUDIES;
GLUCOCORTICOIDS;
HUMANS;
MALE;
MIDDLE AGED;
PSORIASIS;
REFERENCE VALUES;
SENSITIVITY AND SPECIFICITY;
SKIN ABSORPTION;
STATISTICS, NONPARAMETRIC;
VEHICLES;
|
EID: 0032807315
PISSN: 00119059
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-4362.1999.00782.x Document Type: Article |
Times cited : (105)
|
References (9)
|